BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 22996214)

  • 1. Post-pandemic seroprevalence of 2009 pandemic influenza A (H1N1) virus in Shandong Province, China.
    Liu T; Li Z; Song S; Zhang S; Wang Y; Lin Y; Wang S; Wang X; Xu A; Bi Z
    Jpn J Infect Dis; 2012; 65(5):410-4. PubMed ID: 22996214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroepidemiological study of influenza A (H1N1) pdm09 virus following the 2009-2010 wave in Shandong Province, China.
    Liu T; Li Z; Song S; Zhang S; Wang Y; Wang L; Xu A; Wang X; Bi Z
    Scand J Infect Dis; 2013 Jul; 45(7):552-6. PubMed ID: 23672510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infection with influenza A(H1N1)pdm09 during the first wave of the 2009 pandemic: Evidence from a longitudinal seroepidemiologic study in Dhaka, Bangladesh.
    Nasreen S; Rahman M; Hancock K; Katz JM; Goswami D; Sturm-Ramirez K; Holiday C; Jefferson S; Branch A; Wang D; Veguilla V; Widdowson MA; Fry AM; Brooks WA
    Influenza Other Respir Viruses; 2017 Sep; 11(5):394-398. PubMed ID: 28688210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The seroprevalence of pandemic influenza H1N1 (2009) virus in China.
    Xu C; Bai T; Iuliano AD; Wang M; Yang L; Wen L; Zeng Y; Li X; Chen T; Wang W; Hu Y; Yang L; Li Z; Zou S; Li D; Wang S; Feng Z; Zhang Y; Yu H; Yang W; Wang Y; Widdowson MA; Shu Y
    PLoS One; 2011 Apr; 6(4):e17919. PubMed ID: 21533034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Large Proportion of the Mexican Population Remained Susceptible to A(H1N1)pdm09 Infection One Year after the Emergence of 2009 Influenza Pandemic.
    Veguilla V; López-Gatell H; López-Martínez I; Aparicio-Antonio R; Barrera-Badillo G; Rojo-Medina J; Gross FL; Jefferson SN; Katz JM; Hernández-Ávila M; Alpuche-Aranda CM
    PLoS One; 2016; 11(3):e0150428. PubMed ID: 27003409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pandemic influenza A/H1N1 2009 antibodies in the metropolitan area of Buenos Aires in Argentina.
    Labato MI; Contrini MM; Lazzarini D; Campos AM; Gauna ML; Claros R; López EL; Savy VL; Luna CM
    Int J Infect Dis; 2014 Feb; 19():20-5. PubMed ID: 24211378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serological survey of 2009 H1N1 influenza in residents of Beijing, China.
    Deng Y; Pang XH; Yang P; Shi WX; Tian LL; Liu BW; Li S; Cui SJ; Li Y; Lu GL; Zhang L; Zhang X; Liu B; Seale H; Huang F; Wang QY
    Epidemiol Infect; 2011 Jan; 139(1):52-8. PubMed ID: 20854713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/H1N1 2009.
    Hardelid P; Andrews NJ; Hoschler K; Stanford E; Baguelin M; Waight PA; Zambon M; Miller E
    Health Technol Assess; 2010 Dec; 14(55):115-92. PubMed ID: 21208549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-reactive immunity against influenza viruses in children and adults following 2009 pandemic H1N1 infection.
    Ahmed MS; Jacques LC; Mahallawi W; Ferrara F; Temperton N; Upile N; Vaughan C; Sharma R; Beer H; Hoschler K; McNamara PS; Zhang Q
    Antiviral Res; 2015 Feb; 114():106-12. PubMed ID: 25513756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influenza A(H1N1)pdm09 antibodies after pandemic and trivalent seasonal influenza vaccination as well as natural infection in November 2010 in Hamburg, Germany.
    Cramer J; Mac T; Hogan B; Stauga S; Eberhardt S; Wichmann O; Mertens T; Burchard G
    Euro Surveill; 2012 Jan; 17(2):. PubMed ID: 22264864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A survey of levels of antibodies against influenza viruses in the population of Wuxi City].
    You FX; Sun N; Ma GY; Wang MM; Sa D; Shi C; Wu JL; Lin X; Xiao Y; Qian YH; Jiang Y; Xie J; Ji YY; Guan HX
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Oct; 25(5):351-4. PubMed ID: 22338222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroprevalence following the first wave of pandemic influenza A (H1N1) in Turkey, 2009.
    Gözalan A; Altaş AB; Sevencan F; Akın L; Korukluoğlu G; Kara S; Sevindi DF; Ertek M;
    Jpn J Infect Dis; 2012; 65(1):13-8. PubMed ID: 22274152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in seroprevalence of antibodies to pandemic influenza H1N1 (2009) virus among patients seeking care in China.
    Xu C; Bai T; Wang M; Chen T; Wang L; Chen M; Zeng Y; Fan Ch; Yuan F; Shi J; Sun S; Li D; Wang S; Feng Z; Zhang Y; Yu H; Yang W; Wang Y; Shu Y
    Acta Virol; 2012; 56(4):329-35. PubMed ID: 23237089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroepidemiology of pandemic influenza A (H1N1) 2009 virus infections in Pune, India.
    Tandale BV; Pawar SD; Gurav YK; Chadha MS; Koratkar SS; Shelke VN; Mishra AC
    BMC Infect Dis; 2010 Aug; 10():255. PubMed ID: 20738878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence of Pandemic A(H1N1) pmd09 Virus Antibodies in Mexican Health Care Workers Before and After Vaccination.
    Aguilar-Madrid G; Castelán-Vega JA; Juárez-Pérez CA; Ribas-Aparicio RM; Estrada-García I; Baltierra-Jasso L; Cervantes-Servín N; Méndez-Ortega V; Haro-García LC; Sánchez-Román FR; Ortiz-Navarrete V; Fabila-Castillo LH; Magaña-Hernández A; Chávez-Negrete A; Salamanca-Gómez FA; Jiménez-Alberto A
    Arch Med Res; 2015 Feb; 46(2):154-63. PubMed ID: 25796508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dynamics of infection and the persistence of immunity to A(H1N1)pdm09 virus in Israel.
    Weil M; Shohat T; Bromberg M; Bassal R; Dichtiar R; Mandelboim M; Sofer D; Cohen D; Mendelson E
    Influenza Other Respir Viruses; 2013 Sep; 7(5):838-46. PubMed ID: 23280061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-associated cross-reactive antibody-dependent cellular cytotoxicity toward 2009 pandemic influenza A virus subtype H1N1.
    Jegaskanda S; Laurie KL; Amarasena TH; Winnall WR; Kramski M; De Rose R; Barr IG; Brooks AG; Reading PC; Kent SJ
    J Infect Dis; 2013 Oct; 208(7):1051-61. PubMed ID: 23812238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre- and post-pandemic prevalence of antibodies to the 2009 pandemic influenza A (H1N1) virus in Austrian adults.
    Poeppl W; Poeppl G; Hunger M; Tobudic S; Winkler H; Faas A; Mooseder G; Burgmann H
    J Med Virol; 2012 Sep; 84(9):1331-4. PubMed ID: 22825809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long term effectiveness of adjuvanted influenza A(H1N1)pdm09 vaccine in children.
    Örtqvist Å; Bennet R; Hamrin J; Rinder MR; Lindblad H; Öhd JN; Eriksson M
    Vaccine; 2015 May; 33(22):2558-61. PubMed ID: 25869891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Seroprevalence of pandemic influenza A (H1N1)pdm09 in two regions in Morocco following the 2010-2011 influenza season].
    El Rhaffouli H; El Boukhrissi F; Bajjou T; Laraqui A; Hilali F; Bahji M; El Harrak M; Lahlou Amine I
    Pathol Biol (Paris); 2013 Apr; 61(2):83-6. PubMed ID: 22728009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.